Mr. Meni Morim reports

CANNMART TO PROCESS FIRST INTERNATIONAL EXPORT OF MEDICAL-USE CANNABIS TO AUSTRALIA

Lifeist Wellness Inc.'s wholly owned subsidiary, CannMart Inc., will begin exporting cannabis products to Australia, the first international export and expansion for CannMart, in an agreement with Aura Therapeutics Pty. Ltd., which includes concentrate and live resin vapes, bulk flower, and other refined concentrate products in the quickly developing Australian medical cannabis industry.

"We are excited to bring a diverse range of CannMart products to the Australian market in 2024," said Tom Fay, chief executive officer of Aura Therapeutics. "We have confidence in the anticipated growth of the Australian medical cannabis sector in the coming year and believe our collaboration with CannMart will enable us to capitalize on this expansion by offering an extended range of high-quality products to Australian patients."

"Beginning our exporting journey in Australia brings significant value and opportunities for CannMart," said Daniel Stern, chief executive officer of CannMart. "By fulfilling exports in an array of cannabis product categories, we will be able to expand revenue streams while also building an international brand presence for CannMart and in-house brand Roilty concentrates."

The export agreement with Aura will include exclusive terms to distribute in-house brand Roilty concentrates. With 4 per cent of Australian medical cannabis users choosing THC (tetrahydrocannabinol) extracts as their preferred method of consumption, it creates an international brand expansion opportunity and significant revenue stream with strong margin potential for CannMart in 2024. As the Australian regulations and guidelines surrounding medical cannabis are like those of Canada, there will be efficacy in marketing support and brand development, leveraging proven successes from the Canadian market.

About Lifeist Wellness Inc.

Sitting at the forefront of the postpandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include CannMart, which operates a B2B (business-to-business) wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, including for CannMart Labs, a BHO (butane hash oil) extraction facility producing high-margin cannabis 2.0 products; Australian Vapes, one of Australia's largest on-line retailers of vaporizers and accessories; and Mikra, a biosciences and consumer wellness company developing and selling innovative therapies for cellular health.

We seek Safe Harbor.